Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
BPaL(M) Regimen for the Treatment of MDR/RR-TBMultidrug- and Rifampicin-resistant TuberculosisRecruitingPhase 42024-03-15NCT05381194

13 results · Page 1 of 1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Asan Medical CenterSeoulSouth Korea16